Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · December 30, 2023

Net Remission Rates Associated With Biologic and Small-Molecule Treatments for Ulcerative Colitis

Clinical Gastroenterology and Hepatology


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Gastroenterology and Hepatology
Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data
Clin. Gastroenterol. Hepatol. 2023 Dec 01;21(13)3433-3436.e1, M Kayal, H Posner, E Spencer, JF Colombel, C Stalgis, RC Ungaro

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading